--- title: "RBM, Risk-Based Monitoring | MedTech Terms" description: "Monitoring strategy that targets oversight resources to the highest-risk sites, processes, and data based on a documented risk assessment, replacing 100%…" lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/risk-based-monitoring#term", "name": "Risk-Based Monitoring", "alternateName": [ "RBM", "Risk-Based Quality Management", "RBQM" ], "description": "Risk-Based Monitoring (RBM) is a clinical trial oversight approach that uses a documented risk assessment to direct monitoring resources to the trial elements (sites, processes, data points) most critical to subject safety and data integrity. Rather than performing 100% source data verification (SDV) at every site, sponsors combine centralized statistical monitoring (off-site analytics on EDC data), targeted on-site monitoring focused on critical data and processes, and remote source data review where feasible. The broader practice, Risk-Based Quality Management (RBQM), extends this approach to all quality oversight activities.", "url": "https://medtechterms.com/terms/risk-based-monitoring", "termCode": "risk-based-monitoring", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/risk-based-monitoring#article", "headline": "RBM, Risk-Based Monitoring", "description": "Monitoring strategy that targets oversight resources to the highest-risk sites, processes, and data based on a documented risk assessment, replacing 100% source data verification.", "url": "https://medtechterms.com/terms/risk-based-monitoring", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/risk-based-monitoring" }, "about": { "@id": "https://medtechterms.com/terms/risk-based-monitoring#term" }, "articleSection": "Clinical & Trials", "inLanguage": "en", "keywords": "Risk-Based Monitoring, RBM, Risk-Based Quality Management, RBQM, Clinical & Trials, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-06-20", "dateModified": "2026-06-20", "citation": [ { "@type": "CreativeWork", "name": "FDA Oversight of Clinical Investigations Guidance", "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/oversight-clinical-investigations-risk-based-approach-monitoring", "publisher": { "@type": "Organization", "name": "FDA" } }, { "@type": "CreativeWork", "name": "ICH E6(R3) Good Clinical Practice", "url": "https://www.ich.org/page/efficacy-guidelines", "publisher": { "@type": "Organization", "name": "ICH" } }, { "@type": "CreativeWork", "name": "ClinicalTrials.gov", "url": "https://clinicaltrials.gov/", "publisher": { "@type": "Organization", "name": "NIH" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/edc#term", "name": "Electronic Data Capture", "alternateName": "EDC", "url": "https://medtechterms.com/terms/edc" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/sdv#term", "name": "Source Data Verification", "alternateName": "SDV", "url": "https://medtechterms.com/terms/sdv" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/ich-e6-r3#term", "name": "ICH E6(R3) Good Clinical Practice", "alternateName": "E6(R3)", "url": "https://medtechterms.com/terms/ich-e6-r3" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/iso-14155#term", "name": "ISO 14155", "url": "https://medtechterms.com/terms/iso-14155" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/decentralized-clinical-trial#term", "name": "Decentralized Clinical Trial", "alternateName": "DCT", "url": "https://medtechterms.com/terms/decentralized-clinical-trial" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/dsmb#term", "name": "Data Safety Monitoring Board", "alternateName": "DSMB", "url": "https://medtechterms.com/terms/dsmb" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/trial-master-file#term", "name": "Trial Master File", "alternateName": "TMF", "url": "https://medtechterms.com/terms/trial-master-file" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Clinical & Trials", "item": "https://medtechterms.com/terms?cat=Clinical%20%26%20Trials" }, { "@type": "ListItem", "position": 4, "name": "Risk-Based Monitoring", "item": "https://medtechterms.com/terms/risk-based-monitoring" } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Clinical & Trials](/terms?cat=Clinical%20%26%20Trials) 6. / 7. Risk-Based Monitoring [All terms](/terms) Clinical & Trials [Quality System](/ecosystems/quality-system)[Clinical Evidence](/ecosystems/clinical-evidence)RBM # Risk-Based Monitoring Monitoring strategy that targets oversight resources to the highest-risk sites, processes, and data based on a documented risk assessment, replacing 100% source data verification. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed June 20, 2026 ## Definition Risk-Based Monitoring (RBM) is a clinical trial oversight approach that uses a documented risk assessment to direct monitoring resources to the trial elements (sites, processes, data points) most critical to subject safety and data integrity. Rather than performing 100% [source data verification](/terms/sdv) (SDV) at every site, sponsors combine centralized statistical monitoring (off-site analytics on [EDC](/terms/edc) data), targeted on-site monitoring focused on critical data and processes, and remote source data review where feasible. The broader practice, Risk-Based Quality Management (RBQM), extends this approach to all quality oversight activities. What the regulation says ICH E6(R2) §5.18.3 and E6(R3) §3.10 establish RBM expectations. FDA's 'Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring' guidance (2013, refreshed 2023) is the primary U.S. reference. ## What this means in practice RBM became the default expectation under ICH E6(R2) addendum (2016) and is reinforced in E6(R3) (2023). For device [IDE](/terms/ide) studies, sponsors implementing RBM must produce a documented risk assessment, defined Key Risk Indicators (KRIs) and Quality Tolerance Limits (QTLs), trigger-based monitoring procedures, and centralized monitoring analytics. FDA bioresearch monitoring inspections increasingly evaluate RBM implementation depth. Common pitfalls - • Declaring RBM without a documented risk assessment, the assessment is the foundation; without it, RBM is just reduced SDV. - • Setting KRIs/QTLs without thresholds for action, KRIs that no one acts on add cost without benefit. - • Cutting on-site visits to zero, RBM redistributes monitoring, it doesn't eliminate it. ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Standards ISO 14155 Good clinical practice for clinical investigations of medical devices. ](/terms/iso-14155)[ Clinical & Trials Data Safety Monitoring Board(DSMB) Independent committee that periodically reviews accumulating safety and (sometimes) efficacy data during a trial. ](/terms/dsmb)[ Clinical & Trials Decentralized Clinical Trial(DCT) A trial that uses telehealth, home-based assessments, wearables, and direct-to-patient logistics to reduce or eliminate site visits. ](/terms/decentralized-clinical-trial)[ Clinical & Trials Electronic Data Capture(EDC) Software systems used to collect, manage, and report clinical trial data electronically, replacing paper case report forms. ](/terms/edc) ### Clinical Trials & Evidence · From this learning path [ Clinical & Trials Adaptive Trial Design Trial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data. Adjacent lesson ](/terms/adaptive-trial?from=clinical-trials-and-evidence)[ Clinical & Trials Clinical Evaluation Report(CER) Documented assessment of clinical data demonstrating EU MDR conformity for a device. Adjacent lesson ](/terms/cer?from=clinical-trials-and-evidence)[ Clinical & Trials Adverse Event(AE) Any untoward medical occurrence in a subject, whether or not related to the device. ](/terms/adverse-event?from=clinical-trials-and-evidence)[ Clinical & Trials Feasibility Study Small clinical study evaluating initial safety, usability, and design parameters of an investigational device. ](/terms/feasibility-study?from=clinical-trials-and-evidence) Cited by Where this term appears across MedTech Terms. Learning paths (1) - [Clinical Trials & Evidence](/paths/clinical-trials-and-evidence)Lesson 16 of 18 Ecosystems (2) - [Quality System](/ecosystems/quality-system) - [Clinical Evidence](/ecosystems/clinical-evidence) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 FDA· 1 ICH· 1 NIH· 1 1. [1 FDA Oversight of Clinical Investigations Guidance Verified FDA · fda.gov ](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/oversight-clinical-investigations-risk-based-approach-monitoring) 2. [2 ICH E6(R3) Good Clinical Practice Verified ICH · ich.org ](https://www.ich.org/page/efficacy-guidelines) 3. [3 ClinicalTrials.gov Verified NIH · clinicaltrials.gov ](https://clinicaltrials.gov/) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Clinical evidence intersecting with device security? We support clinical-stage MedTech teams whose investigational devices touch patient data or hospital networks. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Clinical & Trials Acronym RBM Sources 3 Updated 6/20/2026 [Compare with another term](/compare?a=risk-based-monitoring) Learn in 60 seconds Card Lesson Quiz Monitoring strategy that targets oversight resources to the highest-risk sites, processes, and data based on a documented risk assessment, replacing 100% source data verification. - · RBM became the default expectation under ICH E6(R2) addendum (2016) and is reinforced in E6(R3) (2023). - · FDA bioresearch monitoring inspections increasingly evaluate RBM implementation depth. - · The broader practice, Risk-Based Quality Management (RBQM), extends this approach to all quality oversight activities. Remember this Watch out: Declaring RBM without a documented risk assessment, the assessment is the foundation; without it, RBM is just reduced SDV. Related terms - [Electronic Data Capture(EDC) ](/terms/edc) - [Source Data Verification(SDV) ](/terms/sdv) - [ICH E6(R3) Good Clinical Practice(E6(R3)) ](/terms/ich-e6-r3) - [ISO 14155 ](/terms/iso-14155) - [Decentralized Clinical Trial(DCT) ](/terms/decentralized-clinical-trial) - [Data Safety Monitoring Board(DSMB) ](/terms/dsmb) - [Trial Master File(TMF) ](/terms/trial-master-file) You may also need Auto-suggested from Clinical & Trials and shared keywords. - [Contract Research Organization(CRO) ](/terms/cro) - [Good Clinical Practice(GCP) ](/terms/gcp) - [Clinical Evaluation Report(CER) ](/terms/cer) - [ICH E6 Good Clinical Practice(GCP) ](/terms/ich-gcp) - [Due Diligence ](/terms/due-diligence) - [MLOps for Medical Devices(MLOps) ](/terms/mlops-medical-device) [All Clinical & Trials terms](/terms?cat=Clinical%20%26%20Trials) From the Blue Goat network Related resources and services on this topic. - [ MedTech Launchpad MedTech funding rounds, accelerators, and launch resources. ](https://medtechlaunchguide.com) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)